Excessive Biologic Response to IFNβ Is Associated with Poor Treatment Response in Patients with Multiple Sclerosis
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Excessive Biologic Response to IFNβ Is Associated with Poor Treatment Response in Patients with Multiple Sclerosis
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 5, Pages e19262
Publisher
Public Library of Science (PLoS)
Online
2011-05-14
DOI
10.1371/journal.pone.0019262
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Two recombinant human interferon-beta 1a pharmaceutical preparations produce a similar transcriptional response determined using whole genome microarray analysis
- (2011) A.E. Sterin Prync et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Whole genome analysis of the action of interferon-beta
- (2011) M.A. Kauffman et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
- (2010) Robert C Axtell et al. NATURE MEDICINE
- Heterogeneous, Longitudinally Stable Molecular Signatures in Response to Interferon-β
- (2009) M. R. Sandhya Rani et al. Annals of the New York Academy of Sciences
- Neutralizing antibodies explain the poor clinical response to Interferon beta in a small proportion of patients with Multiple Sclerosis: a retrospective study
- (2009) Emilia Sbardella et al. BMC Neurology
- A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis
- (2009) M. Comabella et al. BRAIN
- IFNβ therapy progressively normalizes the increased ex vivo T lymphocyte apoptosis observed in active patients with multiple sclerosis
- (2009) Antonio García-Merino et al. CLINICAL IMMUNOLOGY
- Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor
- (2009) Maria Ban et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- IL-10 interferes directly with TCR-induced IFN-γ but not IL-17 production in memory T cells
- (2009) Sandra Naundorf et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis
- (2009) L. Prosperini et al. EUROPEAN JOURNAL OF NEUROLOGY
- Identification of new sensitive biomarkers for thein vivoresponse to interferon-β treatment in multiple sclerosis using DNA-array evaluation
- (2009) F. Sellebjerg et al. EUROPEAN JOURNAL OF NEUROLOGY
- TLR2 Promotes Th2/Th17 Responses via TLR4 and TLR7/8 by Abrogating the Type I IFN Amplification Loop
- (2009) M. H. Wenink et al. JOURNAL OF IMMUNOLOGY
- IFN- 1a Inhibits the Secretion of Th17-Polarizing Cytokines in Human Dendritic Cells via TLR7 Up-Regulation
- (2009) X. Zhang et al. JOURNAL OF IMMUNOLOGY
- Expression of TH1 and TH17 cytokines and transcription factors in multiple sclerosis patients: Does baseline T-Bet mRNA predict the response to interferon-beta treatment?
- (2009) Jelena Drulovic et al. JOURNAL OF NEUROIMMUNOLOGY
- Monitoring of multiple sclerosis immunotherapy
- (2009) Robert H. Goertsches et al. JOURNAL OF NEUROLOGY
- Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
- (2009) Philip L De Jager et al. NATURE GENETICS
- Early identification of interferon-beta responders by ex vivo testing in patients with multiple sclerosis
- (2008) Elke Wiesemann et al. CLINICAL IMMUNOLOGY
- Interleukin-10 and Interleukin-12 Modulation in Patients with Relapsing-Remitting Multiple Sclerosis on Therapy with Interferon-beta 1a: Differences in Responders and Non Responders
- (2008) Pietro B. Carrieri et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- BAFF is a Biological Response Marker to IFN-β Treatment in Multiple Sclerosis
- (2008) Kaushal S. Gandhi et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- IFN-β1b Induces Transient and Variable Gene Expression in Relapsing-Remitting Multiple Sclerosis Patients Independent of Neutralizing Antibodies or Changes in IFN Receptor RNA Expression
- (2008) Anthony T. Reder et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Inhibition of multiple sclerosis–associated retrovirus as biomarker of interferon therapy
- (2008) Giuseppe Mameli et al. JOURNAL OF NEUROVIROLOGY
- Avonex Combination Trial in relapsing—remitting MS: rationale, design and baseline data
- (2008) JA Cohen et al. Multiple Sclerosis Journal
- Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients
- (2008) J Río et al. Multiple Sclerosis Journal
- Interferon-beta responders and non-responders. A biological approach
- (2008) Antonio Bertolotto et al. NEUROLOGICAL SCIENCES
- Predictive markers for response to interferon therapy in patients with multiple sclerosis
- (2008) S. Malucchi et al. NEUROLOGY
- Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients
- (2008) Lisa G. M. van Baarsen et al. PLoS One
- Interferon signaling and treatment outcome in chronic hepatitis C
- (2008) M. Sarasin-Filipowicz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now